Rainmed Medical Limited (02297) submitted a monthly return on movements in securities for November 2025. The filing shows that its authorised share capital remained 3,800,000,000 ordinary shares with a par value of HKD 0.0001 each, totaling HKD 380,000, the same as the previous month.
The total number of issued shares at the end of November stood unchanged at 1,401,358,800. Under the company’s Pre-IPO Share Option Scheme adopted on 10 December 2021, 22,939,800 share options were outstanding at the beginning of the month. During November, 150,750 share options were cancelled, leaving 22,789,050 options outstanding.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.